Bidding Information
MO HealthNet administers a mature Preferred Drug List (PDL), Diabetic and Medical Supplies Program, and accepts manufacturer submissions for Value Based Agreements. We welcome manufacturer participation and engagement to help jointly serve our members.
You can view our most recent manufacturer bid solicitations online.
For more information, or to submit a Value Based Agreement, please send an email.
Clinical Presentations
New Drug Process
Manufacturers interested in providing MO HealthNet with a clinical presentation must complete the Registration for Clinical Presentation to MO HealthNet form to schedule a virtual presentation with Pharmacy Clinical staff. A virtual meeting will be scheduled at the sole discretion of MO HealthNet. Products currently part of the annual review cycle will only be allowed to present in the month prior to the applicable Advisory Committee meeting. For financial questions or discussions on bid opportunities, please email GWT Contracting.
- For questions regarding current coverage view the Pharmacy Cinical Edits and Preferred Drug Lists.
- For new drugs not previously reviewed by the MO HealthNet Pharmacy Advisory Committees view Drugs with Coverage Limitations and New Drug Review.
- For questions regarding when PDL drug products undergo their annual review cycle, please view the far right hand column of the PDL List of Preferred and Non-Preferred Agents on the List of Preferred & Non-Preferred Products.
Register to Present
Manufacturers interested in providing MO HealthNet with a clinical presentation must complete the Registration for Clinical Presentation to MO HealthNet form to schedule a virtual presentation with Pharmacy Clinical team. A virtual meeting will be scheduled at the sole discretion of the MO HealthNet. Drugs currently part of the annual review cycle will only be allowed to present in the month prior to the applicable Advisory Committee meeting.
- For questions regarding current coverage view the Pharmacy Cinical Edits and Preferred Drug Lists.
- For new drugs not previously reviewed by the MO HealthNet Pharmacy Advisory Committees view Drugs with Coverage Limitations and New Drug Review.
Contact us
For questions, please email MHD.PharmacyScheduler@dss.mo.gov and a team member will reach out to you.